Problems connected with in vivo labelling of embryonic glycosaminoglycans with Na 2  35 SO 4  in teratological studies.
D000014:Abnormalities, Drug-Induced / Q000196:embryology; D000818:Animals; D001769:Blood / Q000187:drug effects; D001774:Blood Chemical Analysis; D002623:Chemistry Techniques, Analytical; D002845:Chromatography; D004622:Embryo, Mammalian / Q000378:metabolism*; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism*; D007553:Isotope Labeling; D011247:Pregnancy; D011874:Radiometry; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D012980:Sodium Salicylate / Q000494:pharmacology; D013431:Sulfates / Q000378:metabolism; D013460:Sulfur Isotopes; D014801:Vitamin A / Q000494:pharmacology
D006025:Glycosaminoglycans; D013431:Sulfates; D013460:Sulfur Isotopes; D014801:Vitamin A; D012964:Sodium; D012980:Sodium Salicylate